Trial site
McGill University Health Centre (MUHC)
- 13running trials
- 8closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)3 trials
- Idiopathic pulmonary fibrosis3 trials
- Childhood cancers2 trials
- Coronary artery disease2 trials
- Endometrial cancer2 trials
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Head and neck cancer1 trial
- Heart failure1 trial
- High blood pressure1 trial
- HIV1 trial
- IgA nephropathy1 trial
- and 5 more
- Phase
- Phase 314 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Completed8 trials
- Active, not recruiting6 trials
- Recruiting6 trials
- Not yet recruiting1 trial
- Lead sponsor
- Boehringer Ingelheim9 trials
- Karyopharm Therapeutics Inc2 trials
- AVEO Pharmaceuticals, Inc.1 trial
- Biogen1 trial
- Canadian Myeloma Research Group1 trial
- and 7 more
Running trials
Not yet recruiting
Study of Belantamab Mafodotin, Cevostamab, Pomalidomide for RRMM Patients (MAPLE)
Recruiting
Restrictive Fluid Management In Liver Transplantation (REFIL)
Recruiting
Recruiting
Recruiting
Active, not recruiting
Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
The MARVIN Chatbots to Provide Information for Different Health Conditions
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)2 recruiting
- Childhood cancers1 recruiting
- Head and neck cancer1 recruiting
- HIV1 recruiting
- IgA nephropathy1 recruiting
- Liver cirrhosis1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026